Jul 3 |
GSk snaps six straight days of losses
|
Jul 3 |
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
|
Jul 3 |
GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion
|
Jul 3 |
Trending tickers: SoftBank, Reddit, Vodafone, GSK
|
Jul 3 |
3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024
|
Jul 3 |
CureVac to cut 30% of workforce as GSK buys rights to make flu, covid shots
|
Jul 1 |
Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
|
Jun 27 |
GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1?
|
Jun 27 |
GSK stock falls as CDC shifts RSV vaccine recommendation
|
Jun 27 |
GSK Shares Slump After CDC Narrows Age Recommendation for RSV Shots
|